# ERYTHROMYCIN ETHYLSUCCINATE
> **ANDA062200** · Abbreviated New Drug Application (Generic) · Sponsor: ALPHARMA US PHARMS · Approved 1981-08-11
## Drug
- **FDA Application Number:** ANDA062200
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERYTHROMYCIN ETHYLSUCCINATE
- **Generic name:** Erythromycin Ethylsuccinate
- **Active ingredients:** ERYTHROMYCIN ETHYLSUCCINATE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ALPHARMA US PHARMS
- **First approval:** 1981-08-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062200)
---
*MORVS · CC0 1.0*